International Biotechnology Trust plc (IBT) — Cash Flow Reinvestment Rate

Latest as of August 2025: 1.00x

International Biotechnology Trust plc (IBT) has a Cash Flow Reinvestment Rate of 1.00x as of August 2025, reinvesting GBX31.30 Million (capex GBX31.30 Million ) from operating cash flow of GBX31.30 Million. Explore IBT capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

1.00x
(Capex + Investments) / Operating CF

Total Reinvested

GBX31.30 Million
Capex + Investments

Operating Cash Flow

GBX31.30 Million
GBX

Capital Expenditures

GBX31.30 Million
GBX

International Biotechnology Trust plc Cash Flow Reinvestment Rate (2012–2025)

Historical reinvestment intensity for International Biotechnology Trust plc across 10 annual periods. Also explore International Biotechnology Trust plc asset portfolio for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for International Biotechnology Trust plc (2012–2025)

Year-by-year capital reinvestment analysis for International Biotechnology Trust plc. For live market cap and broader valuation context, see market cap of International Biotechnology Trust plc.

Year Reinvestment Rate Total Reinvested (GBX) Operating CF Capex YoY Change
2025 1.00x GBX28.63 Million GBX28.63 Million GBX28.63 Million ▲ +0.0%
2024 1.00x GBX45.35 Million GBX45.35 Million GBX45.35 Million
2023 0.00x GBX0.00 GBX27.30 Million GBX0.00
2022 0.00x GBX0.00 GBX1.12 Million GBX0.00
2019 0.00x GBX0.00 GBX6.47 Million GBX0.00
2018 0.00x GBX0.00 GBX16.17 Million GBX0.00
2017 0.00x GBX0.00 GBX14.71 Million GBX0.00
2016 0.00x GBX0.00 GBX21.47 Million GBX0.00
2015 0.00x GBX0.00 GBX38.90 Million GBX0.00
2012 0.00x GBX0.00 GBX11.37 Million GBX0.00
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow